SomaGenics 产品代理
SomaGenics 产品代理
SomaGenics, Inc. 成立于 1997 年，是 SRI International 的一项技术衍生公司，已从 NIH、NSF、NASA 和 DARPA 等机构筹集了超过 2500 万美元的联邦赠款资金，并拥有令人印象深刻的知识产权组合，涵盖我们的核酸技术用于生命科学研究、治疗和诊断
small RNA detection: qPCR
RNA based therapeutics: sshRNAs
SomaGenics, Inc. is a privately held company with offices and laboratories located in Santa Cruz, California. We specialize in developing novel RNA-centered approaches to address unmet life science research and medical needs. Our core competencies include RNA molecules as therapeutic agents, drug targets and biomarkers as well as RNA analysis tools. SomaGenics has a proven track record of original research and publication as well as applied development and commercialization.
Founded in 1997 as a technology spin out from SRI International, SomaGenics, Inc. has raised over $25 million in federal grant funding from agencies such as NIH, NSF, NASA and DARPA and maintains an impressive intellectual property portfolio covering our nucleic acid-based technologies for life science research, therapeutics and diagnostics.
SomaGenics, Inc. has enjoyed fruitful collaborations with a number of top academic institutions as well as industry, including Stanford University, MIT, Princeton University, City of Hope, Harvard Medical School, UC Berkeley, UCLA, UC San Francisco, UC Santa Cruz and companies such as Roche, Tekmira and Rubicon Genomics (now part of Takara Bio USA).
